Download Files:
Products Details
Product Description
– PCSK9-IN-22 (compound 29) is an orally active inhibitor of PCSK9. PCSK9-IN-22 inhibits the interaction of the protein with LDLR in vivo[1].
Web ID
– HY-160036
Shipping
– Room temperature
Molecular Formula
– C28H30N6O
References
– [1]Phillip Albert Coghlan, et al. Heterocyclic inhibitors of pcsk9. WO2022133529A1. 2022-06-30.
CAS Number
– 2794203-47-5
Molecular Weight
– 466.58
SMILES
– N[C@@H](CCC1)CN1CC2=CC(NC(C3=CC(C4=CC=CC=C4)=CC=N3)=O)=CC(N5C=NC(C)=C5)=C2
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Ser/Thr Protease
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
